Partnership between Oklo and Atomic Alchemy for isotope production

Oklo Inc. and Atomic Alchemy launch a partnership to increase the production of industrial and medical isotopes, essential in various sectors including cancer treatment.

Share:

Partenariat Oklo Atomic Alchemy Isotope

Comprehensive energy news coverage, updated nonstop

Annual subscription

8.25$/month*

*billed annually at 99$/year for the first year then 149,00$/year ​

Unlimited access • Archives included • Professional invoice

OTHER ACCESS OPTIONS

Monthly subscription

Unlimited access • Archives included

5.2$/month*
then 14.90$ per month thereafter

FREE ACCOUNT

3 articles offered per month

FREE

*Prices are excluding VAT, which may vary depending on your location or professional status

Since 2021: 35,000 articles • 150+ analyses per week

Against a backdrop of worldwide shortages of medical and industrial isotopes, Oklo Inc. and Atomic Alchemy announce strategic partnership to increase production of essential isotopes. This partnership leverages Oklo’s capabilities in fast fission technology and nuclear fuel recycling with Atomic Alchemy’s expertise in isotope production. Together, they plan to build and operate fast reactors that will not only be a source ofclean energy production, but also a platform for the production of vital isotopes for medical diagnostics, cancer treatment and industrial applications.

Technology and innovation at the heart of the partnership

Oklo’s fast reactors and advanced fuel recycling processes form the technological basis of this partnership. These technologies will enable the production of a wide range of isotopes, including those currently in critical short supply, such as those used in radioisotope thermoelectric generators and advanced cancer therapies. Oklo uses a reactor technology that optimizes the use of nuclear fuel and minimizes waste, while increasing the efficiency of isotope production.

Economic and security implications

This partnership is strategic not only from a technological point of view, but also from an economic and security one. By increasing domestic isotope production, the USA could reduce its dependence on foreign sources, often located in geopolitically unstable areas. This initiative is all the more relevant given that global demand for medical isotopes is rising steadily, fuelled by advances in cancer diagnosis and treatment technologies.

Challenges and prospects

The partnership between Oklo and Atomic Alchemy is not without its challenges. The complexity of isotope production requires considerable investment in research and development, as well as strict regulatory safeguards to ensure the safety and efficacy of the isotopes produced. However, the heads of both companies, Jacob DeWitte of Oklo and Thomas Eiden of Atomic Alchemy, are confident in their ability to overcome these obstacles thanks to their combined expertise and the support of their strategic and financial partners.
The partnership between Oklo and Atomic Alchemy is a bold step forward in securing the supply of isotopes vital to many sectors. It represents not only a technological breakthrough, but also a strategic initiative that could redefine energy production and public health standards in the United States.

The Indian government has introduced a bill allowing private companies to build and operate nuclear power plants, ending a state monopoly in place for over five decades.
Natura Resources enters a new regulatory phase for its molten salt reactor MSR-1, following the signing of a framework agreement with the US Department of Energy under the Reactor Pilot Program.
Norwegian Nuclear Decommissioning is surveying 22 localities to assess their interest in hosting storage facilities for radioactive waste from the country’s former research reactors.
Electricité de France's Flamanville 3 reactor has reached full power for the first time, marking a key industrial milestone in the deployment of EPRs in Europe, despite cost overruns reaching EUR23.7bn ($25.7bn).
GE Vernova Hitachi’s BWRX-300 small modular reactor has passed a key regulatory hurdle in the United Kingdom, opening the door to potential commercial deployment, despite no current plans for construction.
Molten salt reactor developer Natura Resources has acquired Shepherd Power and partnered with NOV to scale up modular reactor manufacturing by the next decade.
China National Nuclear Corporation expects commercial operation in 2026 for its ACP100 reactor, following successful cold testing and completion of critical structures in 2025.
Start-up SEATOM has been selected to join NATO's DIANA programme with its micro nuclear reactor designed for extreme environments, reinforcing its position in dual-use marine and military energy technologies.
The Estonian Ministry of Economic Affairs has opened a tender to select a site and conduct initial environmental studies for a 600 MW nuclear power plant, marking a decisive step for the country’s energy future.
The European Commission has approved Poland's financial support plan for its first nuclear power plant, a €42bn project backed by public funding, state guarantees, and a contract for difference mechanism.
Six European nuclear authorities have completed the second phase of a joint review of the Nuward modular reactor, a key step toward aligning regulatory frameworks for small nuclear reactors across Europe.
US fusion energy leaders have called on the federal government to redirect public funding towards their projects, arguing that large-scale investment is needed to stay competitive with China.
Santee Cooper has approved a memorandum of understanding with Brookfield Asset Management to assess the feasibility of restarting two unfinished nuclear reactors, with a potential $2.7 billion payment and 550 MW capacity stake.
Helical Fusion has signed a landmark agreement with Aoki Super to supply electricity from fusion, marking a first in Japan’s energy sector and a commercial step forward for the helical stellarator technology.
India’s nuclear capacity is expected to grow by more than 13,000 MW by 2032, driven by ongoing heavy water reactor construction, new regional projects and small modular reactor development by the Bhabha Atomic Research Centre.
NextEra Energy has lifted its earnings estimates for 2025 and 2026, supported by power demand linked to long‑term contracts previously signed with Google and Meta to supply their artificial intelligence data centres with low‑carbon electricity.
London launches a complete regulatory overhaul of its nuclear industry to shorten authorisation timelines, expand eligible sites, and lower construction and financing costs.
Finland's Ministry of Economic Affairs extends the deadline to June 2026 for the regulator to complete its review of the operating licence for the Olkiluoto spent nuclear fuel repository.
Framatome will replace several digital control systems at the Columbia plant in the United States under a contract awarded by Energy Northwest.
The conditional green light from the nuclear regulator moves Cigéo into its final regulatory stage, while shifting the risks towards financing, territorial negotiations and industrial execution.

All the latest energy news, all the time

Annual subscription

8.25$/month*

*billed annually at 99$/year for the first year then 149,00$/year ​

Unlimited access - Archives included - Pro invoice

Monthly subscription

Unlimited access • Archives included

5.2$/month*
then 14.90$ per month thereafter

*Prices shown are exclusive of VAT, which may vary according to your location or professional status.

Since 2021: 30,000 articles - +150 analyses/week.